BOAN BIOTECH (06955) announced its annual performance, with a net profit attributable to shareholders of 7.144 million yuan, a year-on-year decrease of 90.24%.
Boan Biotech (06955) released its annual performance for the year ended December 31, 2025. The Group's revenue was RMB 785 million, an increase of 8.06% year-on-year; net profit attributable to shareholders was RMB 7.144 million, a decrease of 90.24% year-on-year; earnings per share was RMB 0.01.
BOAN BIOTECH (06955) released its full-year performance for the year ended December 31, 2025, with a group income of RMB 785 million, an increase of 8.06% year-on-year; shareholders' net profit was RMB 7.144 million, a decrease of 90.24% year-on-year; earnings per share was RMB 0.01.
Related Articles
BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.
XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.
Yik Wo International (08659) announces financial performance for 2025. The attributable loss for the year is expected to be approximately 6.773 million yuan, a year-on-year change from profit to loss.
BBSB INTL (08610) reported an annual net profit attributable to shareholders of 6.289 million Ringgit, a decrease of 75.99% year-on-year.
XINHUA LANDE (08106) releases its financial performance for the year 2025, with a net profit of 108.7 million yuan.
Yik Wo International (08659) announces financial performance for 2025. The attributable loss for the year is expected to be approximately 6.773 million yuan, a year-on-year change from profit to loss.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
